Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 double-blind randomized placebo-controlled trial of MultiStem in adults with ischemic stroke
2012-005749-18Phase 2Completed
- Sponsor
- Athersys, Inc.
- Start
- Jan 2013
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ischemic stroke comparing MultiStem with Placebo (2 arms). Primary endpoint: Functional outcome at Day 90 (primary). Started Jan 2013; status: completed.
02
Drugs
invimestrocel
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2012-005749-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005749-18.